Kelly J. Ko, Phd Email & Phone Number

San Diego, Ca, Us

San Diego, Ca, Us

Launched Sharp Ventures, Sharp HealthCare's Innovation program. Planning, leading, and implementation of key innovation and strategic priorities with emphasis on the intersection of technology, data, and digital health for early adoption or co-development. Emphasis on strategic partnerships to diversify revenue and commercialization opportunities.

San Diego, Ca, Us

Lead development and implementation of Enterprise Data Governance, Interoperability, Innovation and Research technology strategy including resource forecasting (staffing and technology), ongoing capability and capacity planning, and regulatory compliance. Key accomplishments and "firsts" for the organization include: Designing a customized Data Literacy program, partnering with academia in facilitating a healthcare themed Hackathon, and developing a formal enterprise Innovation program and launch strategy. Bernstein, P., Ko, K.J. et al. (2021). Urgent and Non-emergent Telehealth Care for Seniors: Findings from a Multi-site Impact Study. Journal of Telemedicine and Telecare. Advance online publication. https://pubmed.ncbi.nlm.nih.gov/33866894/

Ottawa, On, Ca

Executive leaders from public and private sector organizations based in North America, the UK, and Europe dedicated to building trusted data strategies to drive innovation leveraging sensitive data safely and responsibly.

San Diego, Ca, Us

Guide and shape the Zahn Innovation Platform (ZIP) Launchpad with strategic guidance and input regarding direction of the ZIP Launchpad and campus entrepreneurial initiatives. Support and nurture teams helping shape their experiences, participate in fundraising activities to help launch new programs and resources, and provide connectivity to the larger San Diego entrepreneurial and business community.

La Jolla, Ca, Us

Oversee $15M+ in support of the Institute’s strategic plan and priority areas in Clinical research and Data Science. Developed public/private partnership with local government and secured commitment from C-suite leadership at all health systems in San Diego to become the first county in the Country formally designated as senior-friendly. Led a team in the creation of a sustainability plan for key investments in a national learning collaborative including 21 health systems and 4 professional societies. Lesser, A., Israni, J., Lo, A.S. & Ko, K.J. (2020). Older adult visits to the emergency department for ambulatory care sensitive conditions. JACEP Open.Ko, K.J. et al. (Jan 2020). Emerging Priorities and Opportunities in Geriatric Emergency Care. [Special issue]. Generations. 42-47. Kent, T., Lesser, A., Israni, J., Hwang, U., Carpenter, C. & Ko, K.J. (2019). 30-Day Emergency Department Revisit Rates among Older Adults with Documented Dementia. Journal of the American Geriatrics Society. 67(11), 2254-2259.A Practical Guide to Implementing Telehealth in Post-Acute and Long-term Care Settings. (2019). West Health Institute. San Diego, CA. Castillo, E.M., Brennan, J.J., Howard, J. Hsia, R.Y., Chalmers, C. Chan, T.C. & Ko, K.J. (2019). Factors associated with geriatric frequent users of emergency departments. Annals of Emergency Medicine. 74(2), 270-275.A Practical Guide to Implementing a Geriatric Emergency Department. (2018). University of California San Diego Health & West Health Institute. San Diego, CA.

La Jolla, Ca, Us

Develop, maintain, and execute on a broad portfolio of applied medical research, including design and launch of a national accreditation program for organizations demonstrating excellence in Geriatric care, 120+ institutions accredited in under 2 years. Support growth of a national learning collaborative comprised of 4 professional societies and 9 academic institutions providing training, implementation and research services. Partnered with key opinion leaders to secure $500k in federal funding to sustain key organizational initiatives and publish 2 implementation manuals focused on priority areas in telehealth and geriatric emergency medicine. Lesser, A., Israni, J., Kent, T. & Ko, K.J. (2018). Association between physical therapy in the emergency department and emergency department revisits for older adult fallers: A nationally representative analysis. Journal of the American Geriatrics Society, 66(11), 2205-2212. Israni, J., Lesser, A., Kurliand, M., Agha, Z. & Ko, K.J. "Measuring Telehealth: Finding the Right Measure or Asking the Wrong Question?" American Telemedicine Association Blog. 20, Aug. 2018. Volbrecht, M., Biese, K. Hastings, S.N., Ko, K.J. & Previll, L.A. (2018). Systems-Based Practice to Improve Care Within and Beyond the Emergency Department. Clin Geriatr Med, 34(3), 399-413.Israni, J. Lesser, A. Kent, T., & Ko, K.J. (2018). Delirium as a Predictor of Mortality in US Medicare Beneficiaries discharged from the Emergency Department: A National Claims-level Analysis up to 12 months. BMJ Open. 2018;8(5): e021258.Ko, K.J. et al. "The Journey Of Geriatric Emergency Medicine: Acceleration, Diffusion, And Collaboration As Keys To Continued Growth." Health Affairs Blog. 12, Sept. 2017.

San Diego, Ca, Us

Develop all course curriculum, teach, and conduct student evaluations for graduate level course in Biostatistics within the Hahn School of Nursing and Health Sciences.

Kansas City, Missouri, Us

Manage a team of subject matter experts working with internal and external stakeholders to provide population health and research consulting services for clients domestic and abroad. Work with senior leadership to develop annual budgets and strategic planning for the research business unit. Serve as the research lead supporting development activities for multiple business units, notably opportunities to leverage technology to assess study recruitment, feasibility, and connecting potential candidates and providers with clinical trial opportunities. Mentor associates through coaching, performance reviews, and stretch assignments. Aguilar, K.M., Shah, E. & Ko, K.J. (2016). What Does the Future of Phase III Clinical Trials Look Like in a Population Health Model? Clinical Researcher. 30(2), 61-66.Mosa ASM, Yoo I, Apathy, NC, Ko, KJ, Parker JC. Secondary Use of Clinical Data to Enable Data-Driven Translational Science with Trustworthy Access Management. Mo Med. 2015;112(6):443-448.Yeaman, B., Ko, K.J., del Castillo, R. (September 30, 2015). "Care Transitions in Long-term Care and Acute Care: Health Information Exchange and Readmission Rates". OJIN: The Online Journal of Issues in Nursing. Vol. 20, No. 3.

Kansas City, Missouri, Us

Provide consulting services leveraging research, technology, and data in developing population health and research strategy. Leverage large clinical databases, including electronic health records, claims data, and regional health information exchanges' in the conduct of real-world observational studies and quality improvement initiatives presenting findings/recommendations at client sites and professional meetings. Collaborate with cross-functional teams (engineering, policy) to identify opportunities with pharmaceutical, biotech, payer, and provider groups.Aguilar, K.M., Barlow, C., Dean, B.B. & Ko, K.J. (June, 2014). Increasing provider engagement in clinical research starts with research awareness: Leveraging education and technology to improve participation. Clinical Researcher, 30-35.Ko, K.J., et al. (2014). Implementation of a pharmacy-based adult vaccine benefit: Recommendations for a commercial health plan benefit. Journal of Managed Care Pharmacy, 20(3), 273-282.Ko, K.J. et al. (2013). Towards a more efficient approach to data monitoring: Current and future state. The Monitor. 27(6), 31-34.Dean B., Ko, K.J., et al. (2013). Transparency in evidence evaluation and formulary decision making. Pharmacy & Therapeutics, 38(8), 465-483.

Kansas City, Missouri, Us

Provide strategic recommendations via comparative effectiveness research for pharmaceutical, biotech, and payers. Collaborate with clients to publish real-world observational studies to help inform off-label, and formulary decisions. Lead consensus meetings on market access and value messaging across multiple therapeutic areas in various stages of development from Phase II through Phase IV clinical trials. Lead proposal development, including project timeline and scope, including: ∙ Survey development, administration, and evaluation for patients, providers, and payers∙ Systematic literature reviews and global value dossiers for submission to regulatory agencies ∙ Peer-review manuscript publication and writing for commercial audiencesKo,K.J., et al. (2010). Does type of bolus insulin matter in the hospital? Comparison of outcomes between patients receiving analog vs. human insulin. Clinical Therapeutics 32(11), 1954-1963.

Phd, Psychology (Health & Development)

Ms, Developmental Psychology

Ba, Psychology